The latest information

Antleron and Tuatara Dx team up to revolutionize point-of-need diagnostics

Trends Gazellen 2024 nomination for Antleron

Antleron joins Flemish-Brabant advanced therapy delegation to Heidelberg-Mannheim ecosystem

Belgians send miniature heart into space for ageing research

Scilife and Antleron Forge Unique Partnership to Integrate Quality into Personalized Medicine

Antleron ranked No 8 among the fastest growing, small enterprises in Flemish-Brabant

Antleron nominated for 2023 Flemish-Brabant Trends Gazellen

Antleron second best scale-up at the Leuven Innovation Awards

Jan Schrooten joins MEDVIA board of directors

Antleron will again co-organize the Life-on-Chip conference

Antleron in silico solutions driven by Ansys simulations

Antleron & VivaBioCell collaborate toward sustainable adv. therapy manuf. thru bioreactor innovation

X-Pure®–by-design : Antleron-Rousselot® collaborative-development partnership

Collaboration with Novasign to develop novel digital tools to tackle bioprocess developm. challenges

Antleron participates in flanders.healthTech cluster bridging technologies for healthcare innovation

Persomed to develop innovative colon cancer vaccine

3D Systems and Antleron Collaborating to Accelerate 3D Printing Biomedical Breakthroughs